tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CELC Stock Latest News

5 Stocks That Moved the Most in 2025 – What Lies Ahead
Market News5 Stocks That Moved the Most in 2025 – What Lies Ahead
16d ago
RGC
ABVX
Wells Fargo bullish on Celcuity, initiates with an Overweight
PremiumThe Fly
Wells Fargo bullish on Celcuity, initiates with an Overweight
27d ago
CELC
Celcuity initiated with an Overweight at Wells Fargo
PremiumThe Fly
Celcuity initiated with an Overweight at Wells Fargo
27d ago
CELC
Short Report: Core Scientific short interest at record high
PremiumThe Fly
Short Report: Core Scientific short interest at record high
2M ago
CAR
CELC
Celcuity Submits NDA for Gedatolisib to FDA
PremiumCompany Announcements
Celcuity Submits NDA for Gedatolisib to FDA
2M ago
8K
CELC
Celcuity submits gedatolisib new drug application to the FDA
PremiumThe FlyCelcuity submits gedatolisib new drug application to the FDA
2M ago
CELC
Celcuity initiated with an Outperform at Wolfe Research
Premium
The Fly
Celcuity initiated with an Outperform at Wolfe Research
2M ago
CELC
Block upgraded, Dell downgraded: Wall Street’s top analyst calls
Premium
The Fly
Block upgraded, Dell downgraded: Wall Street’s top analyst calls
2M ago
GAP
HPE
Celcuity downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Celcuity downgraded to Neutral from Buy at H.C. Wainwright
2M ago
CELC
Celcuity’s Gedatolisib: A Promising Standard for 2L Breast Cancer Treatment
PremiumRatings
Celcuity’s Gedatolisib: A Promising Standard for 2L Breast Cancer Treatment
2M ago
CELC
Celcuity Inc. Earnings Call: Strong Progress Amid Challenges
PremiumCompany Announcements
Celcuity Inc. Earnings Call: Strong Progress Amid Challenges
2M ago
CELC
Celcuity price target raised to $108 from $96 at Craig-Hallum
PremiumThe Fly
Celcuity price target raised to $108 from $96 at Craig-Hallum
2M ago
CELC
Celcuity price target raised to $115 from $68 at Stifel
PremiumThe FlyCelcuity price target raised to $115 from $68 at Stifel
2M ago
CELC
Celcuity’s Strategic Advances and Robust Financials Justify Buy Rating
Premium
Ratings
Celcuity’s Strategic Advances and Robust Financials Justify Buy Rating
2M ago
CELC
Celcuity Inc. Reports Q3 2025 Financial Progress
Premium
Company Announcements
Celcuity Inc. Reports Q3 2025 Financial Progress
2M ago
CELC
Celcuity’s Gedatolisib: A Promising Standard for 2L Breast Cancer Treatment
PremiumRatings
Celcuity’s Gedatolisib: A Promising Standard for 2L Breast Cancer Treatment
2M ago
CELC
Celcuity reports Q3 adjusted EPS (78c), consensus (96c)
PremiumThe Fly
Celcuity reports Q3 adjusted EPS (78c), consensus (96c)
2M ago
CELC
Is CELC a Buy, Before Earnings?
PremiumPre-Earnings
Is CELC a Buy, Before Earnings?
2M ago
CELC
Short Report: AST SpaceMobile bears return after violent squeeze
PremiumThe Fly
Short Report: AST SpaceMobile bears return after violent squeeze
2M ago
KSS
ASTS
Celcuity Inc.’s Promising Phase 3 Breast Cancer Study: A Market Game-Changer?
PremiumCompany AnnouncementsCelcuity Inc.’s Promising Phase 3 Breast Cancer Study: A Market Game-Changer?
2M ago
CELC
Celcuity’s Phase 3 Breast Cancer Study: A Potential Game-Changer?
Premium
Company Announcements
Celcuity’s Phase 3 Breast Cancer Study: A Potential Game-Changer?
2M ago
CELC
Celcuity Inc.’s Promising Study on mCRPC Treatment: Key Insights for Investors
Premium
Company Announcements
Celcuity Inc.’s Promising Study on mCRPC Treatment: Key Insights for Investors
2M ago
CELC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >